|
|
||||||||||
|
Click on image to view larger version.
Figure 2 One-year clinical outcomes in patients with unstable and stable ischemic syndromes treated with paclitaxel-eluting versus bare-metal stents. MACE = major adverse cardiac events; TVR = target vessel revascularization.
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |